Human Rotavirus Vaccine Market Report

Europe Human Rotavirus Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 20, 2019
  • PAGES：187
  • REPORT CODE：GMM405391
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Human Rotavirus Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Rotavirus Vaccine Market Segmentations:

    By Player:

    • GlaxoSmithKline

    • Merck

    • Bharat Biotech

    By Type:

    • Rotarix

    • RotaTeq

    • Rotavac

    • Rotavin-M1

    • Lanzhou lamb

    • Others

    By End-User:

    • Hospitals & Clinics

    • Academic And Research

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Rotavirus Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotarix from 2014 to 2026

    • 1.3.2 Europe Human Rotavirus Vaccine Market Size and Growth Rate of RotaTeq from 2014 to 2026

    • 1.3.3 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotavac from 2014 to 2026

    • 1.3.4 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotavin-M1 from 2014 to 2026

    • 1.3.5 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Lanzhou lamb from 2014 to 2026

    • 1.3.6 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Hospitals & Clinics from 2014 to 2026

    • 1.4.2 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Academic And Research from 2014 to 2026

    • 1.4.3 Europe Human Rotavirus Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Rotavirus Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Rotavirus Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Rotarix

      • 3.4.2 Market Size and Growth Rate of RotaTeq

      • 3.4.3 Market Size and Growth Rate of Rotavac

      • 3.4.4 Market Size and Growth Rate of Rotavin-M1

      • 3.4.5 Market Size and Growth Rate of Lanzhou lamb

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Human Rotavirus Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Rotavirus Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Rotavirus Vaccine for Hospitals & Clinics

      • 4.4.2 Market Size and Growth Rate of Human Rotavirus Vaccine for Academic And Research

      • 4.4.3 Market Size and Growth Rate of Human Rotavirus Vaccine for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Rotavirus Vaccine Production Analysis by Top Regions

    • 5.2 Europe Human Rotavirus Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Rotavirus Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Rotavirus Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Rotavirus Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Rotavirus Vaccine Landscape Analysis

    • 7.1 Germany Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    8. UK Human Rotavirus Vaccine Landscape Analysis

    • 8.1 UK Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 8.2 UK Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    9. France Human Rotavirus Vaccine Landscape Analysis

    • 9.1 France Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 9.2 France Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    10. Italy Human Rotavirus Vaccine Landscape Analysis

    • 10.1 Italy Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    11. Spain Human Rotavirus Vaccine Landscape Analysis

    • 11.1 Spain Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    12. Poland Human Rotavirus Vaccine Landscape Analysis

    • 12.1 Poland Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    13. Russia Human Rotavirus Vaccine Landscape Analysis

    • 13.1 Russia Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Human Rotavirus Vaccine Landscape Analysis

    • 14.1 Switzerland Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    15. Turkey Human Rotavirus Vaccine Landscape Analysis

    • 15.1 Turkey Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Rotavirus Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Human Rotavirus Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Human Rotavirus Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Human Rotavirus Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Human Rotavirus Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Rotavirus Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Rotavirus Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Rotavirus Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Rotavirus Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Human Rotavirus Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Rotavirus Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GlaxoSmithKline

      • 19.1.1 GlaxoSmithKline Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Merck

      • 19.2.1 Merck Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Bharat Biotech

      • 19.3.1 Bharat Biotech Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    The List of Tables and Figures (Totals 87 Figures and 153 Tables)

    • Figure Product Picture

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotarix from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of RotaTeq from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotavac from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Rotavin-M1 from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Lanzhou lamb from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Hospitals & Clinics from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Academic And Research from 2014 to 2026

    • Figure Europe Human Rotavirus Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Rotavirus Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Rotavirus Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Rotavirus Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Rotavirus Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Human Rotavirus Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rotarix

    • Figure Market Size and Growth Rate of RotaTeq

    • Figure Market Size and Growth Rate of Rotavac

    • Figure Market Size and Growth Rate of Rotavin-M1

    • Figure Market Size and Growth Rate of Lanzhou lamb

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Rotavirus Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Rotavirus Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals & Clinics

    • Figure Market Size and Growth Rate of Academic And Research

    • Figure Market Size and Growth Rate of Others

    • Table Europe Human Rotavirus Vaccine Production by Major Regions

    • Table Europe Human Rotavirus Vaccine Production Share by Major Regions

    • Figure Europe Human Rotavirus Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Human Rotavirus Vaccine Consumption by Major Regions

    • Table Europe Human Rotavirus Vaccine Consumption Share by Major Regions

    • Table Germany Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table France Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Rotavirus Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table UK Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table France Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Rotavirus Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Rotavirus Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Rotavirus Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Rotavirus Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Bharat Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech

    • Figure Sales and Growth Rate Analysis of Bharat Biotech

    • Figure Revenue and Market Share Analysis of Bharat Biotech

    • Table Product and Service Introduction of Bharat Biotech

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US